Literature DB >> 11752143

Paired charge-to-alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypes.

Kathryn A Hanley1, Jay J Lee, Joseph E Blaney, Brian R Murphy, Stephen S Whitehead.   

Abstract

Charge-to-alanine mutagenesis of dengue virus type 4 (DEN4) NS5 gene generated a collection of attenuating mutations for potential use in a recombinant live attenuated DEN vaccine. Codons for 80 contiguous pairs of charged amino acids in NS5 were individually mutagenized to create uncharged pairs of alanine residues, and 32 recombinant mutant viruses were recovered from the 80 full-length mutant DEN4 cDNA constructs. These mutant viruses were tested for temperature-sensitive (ts) replication in both Vero cells and HuH-7 human hepatoma cells. Of the 32 mutants, 13 were temperature sensitive (ts) in both cell lines, 11 were not ts in either cell line, and 8 exhibited a host range (tshr) phenotype. One tshr mutant was ts only in Vero cells, and seven were ts only in HuH-7 cells. Nineteen of the 32 mutants were 10-fold or more restricted in replication in the brains of suckling mice compared to that of wild-type DEN4, and three mutants were approximately 10,000-fold restricted in replication. The level of temperature sensitivity of replication in vitro did not correlate with attenuation in vivo. A virus bearing two pairs of charge-to-alanine mutations was constructed and demonstrated increased temperature sensitivity and attenuation relative to either parent virus. This large set of charge-to-alanine mutations specifying a wide range of attenuation for mouse brain should prove useful in fine-tuning recombinant live attenuated DEN vaccines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11752143      PMCID: PMC136841          DOI: 10.1128/jvi.76.2.525-531.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes.

Authors:  J M Troyer; K A Hanley; S S Whitehead; D Strickman; R A Karron; A P Durbin; B R Murphy
Journal:  Am J Trop Med Hyg       Date:  2001-11       Impact factor: 2.345

2.  Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization.

Authors:  G Winkler; S E Maxwell; C Ruemmler; V Stollar
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

Review 3.  Mutational effects on protein stability.

Authors:  T Alber
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

4.  Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus.

Authors:  C J Lai; B T Zhao; H Hori; M Bray
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

5.  Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice.

Authors:  J E Blaney; D H Johnson; C Y Firestone; C T Hanson; B R Murphy; S S Whitehead
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Dengue-2 vaccine: preparation from a small-plaque virus clone.

Authors:  K H Eckels; V R Harrison; P L Summers; P K Russell
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

8.  Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cells.

Authors:  K H Eckels; R M Scott; W H Bancroft; J Brown; D R Dubois; P L Summers; P K Russell; S B Halstead
Journal:  Am J Trop Med Hyg       Date:  1984-07       Impact factor: 2.345

9.  Liver biochemical tests and dengue fever.

Authors:  C H Kuo; D I Tai; C S Chang-Chien; C K Lan; S S Chiou; Y F Liaw
Journal:  Am J Trop Med Hyg       Date:  1992-09       Impact factor: 2.345

10.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

Authors:  H Nakabayashi; K Taketa; K Miyano; T Yamane; J Sato
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

View more
  40 in total

1.  Replacement of the 3' untranslated variable region of mosquito-borne dengue virus with that of tick-borne Langat virus does not alter vector specificity.

Authors:  Ebenezer Tumban; Dana N Mitzel; Nyree E Maes; Christopher T Hanson; Stephen S Whitehead; Kathryn A Hanley
Journal:  J Gen Virol       Date:  2011-01-07       Impact factor: 3.891

Review 2.  Flavivirus RNA synthesis in vitro.

Authors:  Radhakrishnan Padmanabhan; Ratree Takhampunya; Tadahisa Teramoto; Kyung H Choi
Journal:  Methods       Date:  2015-08-10       Impact factor: 3.608

3.  A 3' terminal stem-loop structure in Nodamura virus RNA2 forms an essential cis-acting signal for RNA replication.

Authors:  John J Rosskopf; John H Upton; Lizette Rodarte; Tammy A Romero; Ming-Ying Leung; Michela Taufer; Kyle L Johnson
Journal:  Virus Res       Date:  2010-02-20       Impact factor: 3.303

4.  A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice.

Authors:  Alexander A Rumyantsev; Brian R Murphy; Alexander G Pletnev
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeys.

Authors:  Joseph E Blaney; James Speicher; Christopher T Hanson; Neeraj S Sathe; Stephen S Whitehead; Brian R Murphy; Alexander G Pletnev
Journal:  Vaccine       Date:  2008-06-13       Impact factor: 3.641

6.  Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication.

Authors:  René Assenberg; Eloise Mastrangelo; Thomas S Walter; Anil Verma; Mario Milani; Raymond J Owens; David I Stuart; Jonathan M Grimes; Erika J Mancini
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

Review 7.  Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV005.

Authors:  Anna P Durbin
Journal:  Curr Opin Virol       Date:  2020-10-23       Impact factor: 7.090

8.  Replacement of conserved or variable sequences of the mosquito-borne dengue virus 3' UTR with homologous sequences from Modoc virus does not change infectivity for mosquitoes.

Authors:  Ebenezer Tumban; Nyree E Maes; Erin E Schirtzinger; Katherine I Young; Christopher T Hanson; Stephen S Whitehead; Kathryn A Hanley
Journal:  J Gen Virol       Date:  2012-12-19       Impact factor: 3.891

9.  Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity.

Authors:  Julie H McArthur; Anna P Durbin; Jennifer A Marron; Kimberli A Wanionek; Bhavin Thumar; Dennis J Pierro; Alexander C Schmidt; Joseph E Blaney; Brian R Murphy; Stephen S Whitehead
Journal:  Am J Trop Med Hyg       Date:  2008-11       Impact factor: 2.345

10.  RNA interference modulates replication of dengue virus in Drosophila melanogaster cells.

Authors:  Swati Mukherjee; Kathryn A Hanley
Journal:  BMC Microbiol       Date:  2010-04-27       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.